Menu

Recent Interviews

Dirk Graszt, CEO, Clean Logistics SE

Dirk Graszt
CEO | Clean Logistics SE
Trettaustr.32, 21107 Hamburg (DE)

info@cleanlogistics.de

+49-4171-6791300

Interview Clean Logistics: Hydrogen challenge to Daimler + Co.


Matthew Salthouse, CEO, Kainantu Resources

Matthew Salthouse
CEO | Kainantu Resources
3 Phillip Street #19-01 Royal Group Building, 048693 Singapore (SGP)

info@krl.com.sg

+65 6920 2020

Interview Kainantu Resources: "We hold the key to growth in the Asia-Pacific region".


Justin Reid, President and CEO, Troilus Gold Corp.

Justin Reid
President and CEO | Troilus Gold Corp.
36 Lombard Street, Floor 4, M5C 2X3 Toronto, Ontario (CAN)

info@troilusgold.com

+1 (647) 276-0050

Interview Troilus Gold: "We are convinced that Troilus is more than just a mine".


15. December 2020 | 15:37 CET

Moderna, AdTiger, AstraZeneca - here we go!

  • Investments
Photo credits: pixabay.com

The announcement of the second lockdown last Sunday is a disaster for brick-and-mortar retailers. After an extremely sluggish Christmas season so far, the new closures will turn off the lights for stores during the most critical time of the year. Of the total 560,000 jobs in downtown retail, up to 250,000 are said to be acutely threatened. The beneficiary of this disastrous situation is once again, eCommerce. However, in addition to the major platforms Amazon, Alibaba or Zalando, other Internet companies are also profiting from the online trend.

time to read: 3 minutes by Stefan Feulner
ISIN: KYG009701064 , US60770K1079 , GB0009895292


 

Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author


AdTiger - Digital market booming

Advertising is placed where the customer is. Due to the Corona pandemic and the recurring lockdowns, more and more people migrated away from the offline to the online marketplace. As a result, eCommerce sales worldwide are expected to grow between 15% and 20% this year. Advertising platforms are responsible for ensuring that the customer sees the right things, personalized just for him, in the banners or displays. One of the interesting players is the Chinese advertising platform AdTiger. AdTiger's primary goal is to connect Chinese advertisers who operate internationally with the biggest social media platforms and apps, mainly from the US.

Partnerships with the big players

The Chinese partners read like the crème de la crème of the social media industry. For example, AdTiger is a China Export Partner (CEP) of Facebook and ranked first among Facebook's 23 CEP's in terms of ad spend on Facebook's ad inventory in 2019, and also has an agreement with Google in the AdWords Reseller Program. With Baidu, AdTiger is an authorized Snapchat sales representative. Direct cooperations are also in place with Yahoo and the emerging platform TikTok. Thus, there is enormous potential for the Chinese to direct their customers to all relevant channels.

Expansion of Big Data and Artificial Intelligence

To target advertising correctly, AdTiger uses its own specially programmed software, AdTensor. The program uses artificial intelligence to perform ad optimization and ad management automatically, intelligently, and in real-time. AdTensor's Big Data and AI capabilities make it possible to achieve optimal advertising goals for advertisers. It also helps to leverage the monetization potential of media publishers. Analysis and tracking in the field of artificial intelligence are to be expanded further. For example, AdTiger plans to make a significant addition to its Big Data team this year. The Company's shares have recently been trading at a current price of EUR 0.13 on the Frankfurt Stock Exchange. The market capitalization is currently just under EUR 80.0 million.

AstraZeneca - Record deal in the bag

To expand its business with drugs for rare diseases, AstraZeneca is prepared to put the internal record sum of USD 39 billion on the table for the US biotech Company Alexion. For the acquisition, AstraZeneca plans to pay USD 175 per Alexion share in cash as well as in its securities. The British pharmaceutical Company hopes that this will generate synergies of USD 500 million per year from the end of the third year of the takeover. Above all, profits are expected to bubble up. Double-digit percentage growth in core earnings per share is expected in the first three years after completion of the transaction.

Analysts sceptical

Analysts are less optimistic than the Company itself about the largest acquisition in the Company's history. According to Goldman Sachs, while the proposed deal improves cash inflow dynamics and provides a reasonable degree of diversification, the experts see a risk of diluted and potentially lower organic growth. Investors also took the news negatively, at least in the short term. The share opened with a minus of over 9% but was able to halve the losses in the course of trading.

Moderna - Start in the USA

What is currently still having a negative impact on the share price is the uncertain forecast as to when the British will submit an application for approval of their vaccine. Here, the competitors BioNTech and Pfizer, as well as the US Company Moderna, are months ahead. After an emergency approval by the health authority FDA, the delivery of the Corona vaccine of the Mainz-based pharmaceutical Company BioNTech and its US partner Pfizer is underway in the United States. Freight company FedEx said Sunday that its subsidiary FedEx Express would begin transporting the vaccine, which is frozen with dry ice.


Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

28. October 2021 | 13:20 CET | by Nico Popp

BASF, Memiontec, JinkoSolar: Rich returns with green shares

  • Investments

Chemistry is everything. It is not just since the bestseller "Chemistry for Breakfast" by scientist and YouTuber Mai Thi Nguyen-Kim that people have known how comprehensively chemistry can explain our world. There is also a lot of chemistry involved in future technology, such as filter systems for water or solar panels. We present three stocks and assess their values. We start with one of the best-known chemical stocks, followed by smaller shares with no less interesting business models.

Read

26. October 2021 | 12:05 CET | by Nico Popp

SAP, wallstreet:online, Alibaba: Sentiment Check for Digital Shares

  • Investments

More and more business models are shifting to the Internet. Even traditional industries, such as trades, are benefiting from digital processes. Elsewhere, this transformation is already in full swing, such as in the financial sector. Investors have long since been trading online and only speak to their broker by phone in exceptional cases. We present three digitization stocks and examine their price potential.

Read

20. October 2021 | 12:10 CET | by Carsten Mainitz

Formycon, Memiontec, Synlab - Act before it is too late!

  • Investments

When an unpredictable event occurs, humanity sees how powerless it is in the face of it. We saw this in the spring of last year with the outbreak of the Corona pandemic. Only since the approval of various vaccines has a normalization taken place. However, further, foreseeable problems are coming our way. According to expert forecasts, water demand will exceed supply by 40% as early as 2030. Some companies sense an opportunity to profit from the water shortage through novel technologies.

Read